Highlights
-
Today’s Research Article: PRP beats steroids for chronic plantar fasciitis—lasting relief, better healing, fewer setbacks.
-
Questions from the Field: “PRP is cash pay. No insurance. No clawbacks. No headaches.” —Dr. Ariana DeMers.
-
Let’s Get Down to Business: Struggling to explain PRP without sounding salesy? This video gives you the words that work.
-
Come Join Us: TOBI teaches the science—BOB Live shows you how to turn it into income.
Turn what you learn at TOBI into a thriving cash-based practice at BOB Live.
If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.
Today’s Research Article
Is Platelet-rich Plasma Injection more Effective than Steroid Injection in the Treatment of Chronic Plantar Fasciitis in Achieving Long-term Relief?
Soraganvi P, Nagakiran KV, Raghavendra-Raju RP Anilkumar D, Wooly S, Basti BD, Janakiraman P
Summary:
This double-blind, randomized study conducted at PES Institute of Medical Sciences in India compared the effectiveness of platelet-rich plasma (PRP) versus corticosteroid injections in 60 patients with chronic plantar fasciitis. Both groups showed initial improvement in pain and function, but the PRP group demonstrated continuous improvement over time. At six months, patients treated with PRP reported significantly lower pain scores (VAS 1.41 vs. 3.76) and higher functional scores (AOFAS 90.03 vs. 74.67) than those treated with steroids.
The study also showed a greater reduction in plantar fascia thickness in the PRP group (35.45%) compared to the steroid group (29.16%), indicating better tissue healing. While steroid injections offered quicker short-term relief, their benefits diminished after three months. PRP, enriched with growth factors, promoted sustained healing and functional recovery. These findings suggest PRP as a superior, long-term treatment option for patients with chronic plantar fasciitis unresponsive to conservative therapy.
Doctor-to-Patient Talking Points on Why to Choose PRP (Based on the Study):
